Studies of in vitro evaluation and formulation of aceclofenac loaded PLGA microspheres

International Journal of Pharmacology

Volumn 6, Issue 5, 2010, Pages 726-731

  Gupta, V ^a,b   Shukla, S K ^a,c   Shrivastava, S M ^a   Shukla, S ^c   Kumar, K ^d   Saxena, D P ^d   Shrivastava, B ^b   Chaudhary, M ^a  

^a Venus Medicine Research Center   (India)

^b JAIPUR NATIONAL UNIVERSITY   (India)

^c BUNDELKHAND UNIVERSITY   (India)

^d KUMAUN UNIVERSITY   (India)

Author keywords

Biodegradable; Excipients; Solvent evaporation; Toxicity; Tween80

Indexed keywords

ACECLOFENAC; EXCIPIENT; MICROSPHERE; PHOSPHATE BUFFERED SALINE; POLYGLACTIN; POLYSORBATE 80; POLYVINYL ALCOHOL; SOLVENT;

ANALYTIC METHOD; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL ANALYSIS; CONTENT ANALYSIS; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; ENCAPSULATION; IN VITRO STUDY; PARTICLE SIZE; PH; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE;

EID: 77955682496     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.726.731     Document Type: Article

References (22)

1. Akimoto, H., R. Yamazaki, S. Hashimoto, T. Sato and A. Ito, 2000. 4-Hydroxy aceclofenac suppresses the interleukin-1 induced production of promatrix metalloproteinases and release of sulfated glycosaminoglycans from rabbit articular chondrocytes. Eur. J. Pharmacol, 401: 429-436.
2. Brogden, R.N. and L.R. Wiseman, 1996. Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. Drugs, 52: 113-124.
3. Dashora, K., S. Saraf and S. Saraf, 2006. In-vitro studies of tizanidine controlled release microcapsullar matrices. Pak. J. Pharm. Sci., 19: 177-181.
4. Dubey, R.R. and R.H. Parikh, 2004. Two stage optimization process for formulation of chitosan microspheres. AAPS Pharm. Sci. Tech., 5: 20-28.
5. El-Kousy, N.M., 1999. Spectrophotometric and spectro?uorimetric determination of etodolac and aceclofenac. J. Pharm. Biomed. Anal., 20: 185-194.
6. Govender, S., V. Pillay, D.J. Chetty, S.Y. Essack, CM. Dangor and T. Govender, 2005. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int. J. Pharm., 306: 24-40.
7. Gowda, K.V., D.S. Rajan, U. Mandal, P.S. Selvan and W.D. Sam Solomon et al., 2006. Evaluation of bioequivalence of two formulations containing 100 mg of aceclofenac. Drug Dev. Indus. Pharm., 32: 1219-1225.
8. Kibbe, A.H., 2000. Handbook of Pharmaceutical Excipients. 3rd Edn., American Pharmaceutical Association Press, Washington, DC.
9. Kim, Y.G., Y.J. Lee, H.J. Kim, S.D. Lee and J.W. Kwon et al, 2001. Bioequivalence of two aceclofenac tablet formulations after a single oral dose to healthy male Korean volunteers. Int. J. Clin. Pharmacol. Ther., 39: 83-88.
10. Kim, B.K., S.J. Hwang, J.B. Park and H.J. Park, 2002. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J. Microencapsul., 19: 811-882.
11. Mei, Z., H. Chen, T. Weng, Y. Yang and X. Yang, 2003. Solid lipid nanoparticles and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm., 56: 189-196.
12. Najib, N., N. Idkaidek, M. Beshtawi, M. Bader, I. Admour, S.M. Alam, Q. Zaman and R. Dham, 2004. Bioequivalence evaluation of two brands of aceclofenac 100 mg tablets (Aceclofar and Brista?am) in healthy human volunteers. Biopharm. Drug Dispos., 25: 103-108.
13. Niwa, T., H. Takeuchi, T. Hino, N. Kunou and Y. Kawashima, 1993. Preparation of biodegradable nano-spheres of water soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behaviour. J. Control. Release, 25: 89-98.
14. Niwa, T., H. Takeuchi, T. Hino, N. Kunuo and Y. Kawashima, 1994. In vitro drug release behaviour of DL-Lactide/Glycolide co polymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J. Pharm. Sci., 83: 727-732.
15. Patil, S.S. and P.V. Kasture, 2007. Studies on preparation and evaluation of biodegradable Poly (Lactide-Co-Glycolide) microsphere of aceclofenac. CMU J. Nat. Sci., 6: 195-205.
16. Raber, A., J. Heras, J. Costa, J. Fortea and A. Cobos, 2007. Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam and rofecoxib during the first year after marketing in the United Kingdom. Ther. Clin. Risk Manage., 3: 225-230.
17. Salamone, P.R. and R J. Wodzinski, 1997. Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl. Microbiol. Biotechnol., 48: 317-324.
18. Saudagar, R.B., M. Rawat, D. Singh, S. Saraf and S. Saraf, 2007. Development and validation of derivative spectrophotometric method for determination of serratiopeptidase in pharmaceutical formulation. Oriental. J. Chem., 23: 1057-1060.
19. Tessari, L., L. Ceciliani, A. Belluati, G. Letizia and U. Martorana et al., 1995. Aceclofenac cream versus piroxicam cream in the treatment of patients with minor traumas and phlogistic affections of soft tissues: A double-blind study. Curr. Ther. R es., 56: 702-712.
20. Yamazaki, R., S. Kawai, T. Matsuzaki, N. Kaneda and S. Hashimoto et al., 1997. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. Eur. J. Pharmacol., 329: 181-187.
21. Yang, J.H., K. Young and KM. Kim, 2002. Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system. Arch. Pharm. Res., 25: 534-540.
22. Yong, C.S, Y.K. Oh, K.H. Lee, S.M. Park and Y.J. Park et al., 2005. Trials of clear aceclofenacloaded soft capsules with accelerated oral absorption in human subjects. Int. J. Pharm., 302: 78-83.